(Q44560037)

4 December 2017

0 references

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies (English)

1 reference

4 December 2017

1 reference

1 reference

Stefanos Bonovas

1

1 reference

4 December 2017

Kalitsa Filioussi

series ordinal

2

1 reference

4 December 2017

Nikolaos M Sitaras

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

International Journal of Cancer

4 December 2017

1 reference

4 December 2017

123

1 reference

4 December 2017

899-904

1 reference

4 December 2017

4

1 reference

Global cancer statistics, 2002

4 December 2017

1 reference

Hypertriglyceridemia as a possible risk factor for prostate cancer.

21 January 2018

1 reference

Cholesterol and prostate cancer

21 January 2018

1 reference

Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate

21 January 2018

1 reference

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells

21 January 2018

1 reference

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

21 January 2018

1 reference

Invited commentary: a critical look at some popular meta-analytic methods

21 January 2018

1 reference

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

21 January 2018

1 reference

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

21 January 2018

1 reference

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

21 January 2018

1 reference

Statin use and risk of prostate cancer in the California Men's Health Study cohort

21 January 2018

1 reference

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

21 January 2018

1 reference

Statin use and the risk of 10 cancers.

21 January 2018

1 reference

Statin drugs and risk of advanced prostate cancer

21 January 2018

1 reference

Statins and prostate cancer risk: a case-control study

21 January 2018

1 reference

Cancer risk among statin users: a population-based cohort study

21 January 2018

1 reference

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

Statin use and the risk of breast and prostate cancer

21 January 2018

1 reference

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

Statins and risk of cancer: a systematic review and metaanalysis

21 January 2018

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

21 January 2018

1 reference

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

21 January 2018

1 reference

Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies

21 January 2018

1 reference

Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

21 January 2018

1 reference

Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study

21 January 2018

1 reference

Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.

21 January 2018

1 reference

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?

21 January 2018

1 reference

21 January 2018

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies

21 January 2018

1 reference

The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.23550

1 reference

4 December 2017

1 reference